Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

Phase 4CompletedNCT00140985

Organon and Co97 enrolled

Overview

Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Males or females at least 18 years of age with non-diabetic proteinuric renal diseases

24h proteinuria

Changes in the plasma and urinary levels of TGF-beta

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.